Endurant Capital Management’s bluebird bio BLUE Stock Holding History

Endurant Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,589	Closed	-$765K	–	34
2023 Q3	$765K	Sell	12,589 -1,483	-11%	-$104K	0.69%	35
2023 Q2	$926K	Sell	14,072 -12,181	-46%	-$891K	0.81%	25
2023 Q1	$1.67M	Buy	+26,253	New	+$3M	0.86%	29
2015 Q3	–	Sell	-270	Closed	-$589K	–	80
2015 Q2	$589K	Sell	270 -332	-55%	-$676K	0.17%	81
2015 Q1	$942K	Buy	+602	New	+$794K	0.31%	72

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Endurant Capital Management's BLUE Position: Q4 2023 in Review

Endurant Capital Management sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 12,589 shares — an estimated $765K sold.

Endurant Capital Management first reported a position in BLUE in Q1 2015 and held it in 5 quarters. The position peaked at $1.67M in Q1 2023. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

Endurant Capital Management reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
Endurant Capital Management sold 12,589 bluebird bio shares in Q4 2023, an estimated $765K.
Endurant Capital Management first reported a position in bluebird bio in Q1 2015 and held it in 5 quarters.
Endurant Capital Management's bluebird bio position peaked at $1.67M in Q1 2023.
187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.